EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pharmacological treatment of ectopic pregnancy: Accuracy, safety and cost‐effectiveness of day 1–7 β‐hCG measurements

Adi Dayan-Schwartz iD, Suzan Abd Elgani, Tamam Abdul-Ghani, Liron Kogan, Ari Reiss, Alon Tal

International Journal of Gynecology & Obstetrics · 2024

DOI: 10.1002/ijgo.15511 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Adi Dayan-Schwartz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Emek Medical Center, Afula, Israel. Hauptthemen laut MEDLINE: Methotrexate, Pregnancy, Ectopic, Cost-Benefit Analysis, Chorionic Gonadotropin, beta Subunit, Human. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The aim of the present study was to compare accuracy, safety and cost‐effectiveness of three β‐hCG measurements protocols, applied in managing ectopic pregnancies (EP) with methotrexate (MTX): (1) day 1 to 7 β‐hCG levels, (2) day 1 to 4 β‐hCG levels and (3) day 4 to 7 β‐hCG levels.

Methods

Cost‐minimization analysis (CMA) based on a retrospective study of patients treated with single‐dose MTX for EP, was evaluated at a single institution between January 2001 to May 2021. Successful MTX treatment was defined as no surgical intervention. We evaluated safety by analyzing cases of day 4 interventions and cases of inconsistency between the different protocols. Predicting accuracy was assessed by the area under the receiver operating characteristic (AUC) curve.

Results

A total of 229 patients with single dose MTX treatment were included. Overall, 184 (80.3%) patients were treated successfully with a single dose of MTX. For days 1 and 7 the optimal cutoff point was 7% reduction in β‐hCG levels with sensitivity, specificity and PPV of 76.6% (69.9–82.5, 95% CI), 75.5% (60.5–87.1, 95% CI) and 92.8% (88.4–95.6, 95% CI), respectively. There was no significant difference between the protocols' AUC. None of the patients had any change of management during their day 4 visit in our 20 years of records. The cost for each visit day (day 4 and 7) was calculated with a total cost of 251 USD per patient.

Conclusion

Patients treated with MTX for EP, measurement of day 1 and day 7 β‐hCG serum levels has a cost minimization advantage and is not inferior to the traditional protocol for predictive accuracy and safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexatePregnancy, EctopicCost-Benefit AnalysisChorionic Gonadotropin, beta Subunit, HumanAbortifacient Agents, NonsteroidalHumansFemalePregnancyRetrospective StudiesAdultSensitivity and Specificity

Stichwörter der Autor:innen

early pregnancyectopic pregnancyextra uterine pregnancy (EUP)hospital congestionmethotrexate (MTX)treatment costsβ‐hCG

Substanzen

MethotrexateChorionic Gonadotropin, beta Subunit, HumanAbortifacient Agents, Nonsteroidal

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Emek Medical Center, Afula, Israel.
  • Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Department of Human Biology, University of Haifa, Haifa, Israel.

ORCID-Profile: Adi Dayan-Schwartz

Zitieren

APA

Dayan-Schwartz, A., Abd Elgani, S., Abdul-Ghani, T., Kogan, L., Reiss, A., & Tal, A. (2024). Pharmacological treatment of ectopic pregnancy: Accuracy, safety and cost‐effectiveness of day 1–7 β‐hCG measurements. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15511

Vancouver

Dayan-Schwartz A, Abd Elgani S, Abdul-Ghani T, Kogan L, Reiss A, Tal A. Pharmacological treatment of ectopic pregnancy: Accuracy, safety and cost‐effectiveness of day 1–7 β‐hCG measurements. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.15511

BibTeX
@article{DayanSchwartz2024,
  author = {Dayan-Schwartz, Adi and Abd Elgani, Suzan and Abdul-Ghani, Tamam and Kogan, Liron and Reiss, Ari and Tal, Alon},
  title = {Pharmacological treatment of ectopic pregnancy: Accuracy, safety and cost‐effectiveness of day 1–7 β‐hCG measurements},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2024},
  doi = {10.1002/ijgo.15511}
}
Kostenlos starten →